Short Interest in Aterian, Inc. (NASDAQ:ATER) Expands By 76.9%

Aterian, Inc. (NASDAQ:ATERGet Free Report) saw a large growth in short interest in the month of December. As of December 31st, there was short interest totaling 289,004 shares, a growth of 76.9% from the December 15th total of 163,339 shares. Approximately 3.6% of the company’s shares are short sold. Based on an average daily trading volume, of 79,792 shares, the days-to-cover ratio is presently 3.6 days. Based on an average daily trading volume, of 79,792 shares, the days-to-cover ratio is presently 3.6 days. Approximately 3.6% of the company’s shares are short sold.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Aterian in a research report on Wednesday, October 8th. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Aterian currently has an average rating of “Reduce” and a consensus price target of $4.00.

View Our Latest Analysis on ATER

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in ATER. Goldman Sachs Group Inc. increased its position in shares of Aterian by 73.0% during the first quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock worth $45,000 after acquiring an additional 9,026 shares in the last quarter. Ground Swell Capital LLC acquired a new position in Aterian in the 2nd quarter worth $58,000. XTX Topco Ltd acquired a new position in Aterian in the 2nd quarter worth $55,000. Citadel Advisors LLC increased its holdings in Aterian by 222.0% during the 3rd quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock worth $35,000 after purchasing an additional 22,865 shares in the last quarter. Finally, Susquehanna International Group LLP increased its holdings in Aterian by 310.2% during the 3rd quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock worth $43,000 after purchasing an additional 30,637 shares in the last quarter. Institutional investors and hedge funds own 7.02% of the company’s stock.

Aterian Price Performance

Shares of Aterian stock opened at $0.76 on Thursday. The company has a market capitalization of $7.59 million, a P/E ratio of -0.47 and a beta of 0.03. The business has a 50-day moving average of $0.77 and a two-hundred day moving average of $1.01. Aterian has a 1 year low of $0.64 and a 1 year high of $3.50.

Aterian (NASDAQ:ATERGet Free Report) last released its quarterly earnings data on Thursday, November 13th. The company reported ($0.28) earnings per share for the quarter, beating the consensus estimate of ($0.63) by $0.35. Aterian had a negative return on equity of 47.45% and a negative net margin of 15.73%.The business had revenue of $19.02 million for the quarter, compared to analysts’ expectations of $19.88 million.

Aterian Company Profile

(Get Free Report)

Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.

Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.

Featured Stories

Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.